DURHAM, N.C., - Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) announced today Inspire scientists and collaborators will present data at the American Thoracic Society (ATS) annual meeting May 15 - 20, 2009 in San Diego, CA.
The oral poster presentation, "Phase 3 Study of Denufosol Tetrasodium for the Treatment of Cystic Fibrosis" (R.B. Moss, R.D. Anbar, R.W. Wilmott, M. Barnes, A.E. Schaberg, T.A. Durham, F.J. Accurso), will take place during the poster discussion session, "New Data Regarding Cystic Fibrosis," on Sunday, May 17, 2009 from 8:15 AM - 10:45 AM.
Inspire will also have five presentations related to preclinical work conducted with novel Rho kinase inhibitors in respiratory-related applications.
